The isolated expression of PD-L1 cannot be used as a potential indicator of the benefits of PD-1/PD-L1 inhibitors in the absence of TILs (tumor-infiltrating lymphocytes) [41]. This evidence concerns the gene PDCD1 and neoplasm.